Targeted Therapy

253 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

Targeted Therapy (253)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Molecule	Drug Class / Mechanism	Oncology Type
Cabozantinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Cabozantinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Camonsertib	DNA Damage Response Inhibitor (WEE1/ATR/CHK1)	Solid Tumour
Molecule Camonsertib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)
Capmatinib	RET / MET / KRAS / IDH Inhibitor	Solid Tumour
Molecule Capmatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Carfilzomib	Proteasome Inhibitor	Hematologic (Multiple Myeloma)
Molecule Carfilzomib Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Proteasome Inhibitor
CC-94676	Androgen Receptor Degrader (PROTAC)	Solid Tumour (Prostate)
Molecule CC-94676 Therapeutic Category Targeted Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Androgen Receptor Degrader (PROTAC)
Cediranib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Cediranib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Ceralasertib	DNA Damage Response Inhibitor (WEE1/ATR/CHK1)	Solid Tumour
Molecule Ceralasertib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)
Cerdulatinib	SYK / Multi-Kinase Inhibitor	Hematologic
Molecule Cerdulatinib Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism SYK / Multi-Kinase Inhibitor
Ceritinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Ceritinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Chidamide	HDAC Inhibitor	Hematologic (Lymphoma)
Molecule Chidamide Therapeutic Category Targeted Therapy Oncology Type Hematologic (Lymphoma) Drug Class / Mechanism HDAC Inhibitor
Cobimetinib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Cobimetinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Copanlisib	PI3K Inhibitor	Both (Solid & Hematologic)
Molecule Copanlisib Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor

Cabozantinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Camonsertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)
Capmatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Carfilzomib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Proteasome Inhibitor
CC-94676 Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour (Prostate) Drug Class / Mechanism Androgen Receptor Degrader (PROTAC)
Cediranib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Ceralasertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)
Cerdulatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic Drug Class / Mechanism SYK / Multi-Kinase Inhibitor
Ceritinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Chidamide Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Hematologic (Lymphoma) Drug Class / Mechanism HDAC Inhibitor
Cobimetinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Copanlisib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism PI3K Inhibitor

‹ 1 … 3 4 5 6 7 … 22 ›

Product Range

Company

Global Network

Targeted Therapy

Targeted Therapy (253)

Cabozantinib

Camonsertib

Capmatinib

Carfilzomib

CC-94676

Cediranib

Ceralasertib

Cerdulatinib

Ceritinib

Chidamide

Cobimetinib

Copanlisib

Cabozantinib

Camonsertib

Capmatinib

Carfilzomib

CC-94676

Cediranib

Ceralasertib

Cerdulatinib

Ceritinib

Chidamide

Cobimetinib

Copanlisib